Extendicare Inc. (TSE:EXE – Get Free Report) shares passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of C$7.95 and traded as high as C$9.19. Extendicare shares last traded at C$9.16, with a volume of 49,559 shares changing hands.
Analyst Ratings Changes
A number of research analysts have recently weighed in on EXE shares. Royal Bank of Canada lifted their price target on Extendicare from C$8.50 to C$9.50 in a report on Monday, August 19th. TD Securities lifted their target price on Extendicare from C$9.00 to C$9.50 and gave the company a “hold” rating in a research note on Wednesday, September 4th.
View Our Latest Research Report on Extendicare
Extendicare Stock Performance
Extendicare (TSE:EXE – Get Free Report) last announced its quarterly earnings data on Monday, August 12th. The company reported C$0.29 earnings per share (EPS) for the quarter. Extendicare had a return on equity of 60.00% and a net margin of 4.28%. The business had revenue of C$348.48 million during the quarter, compared to analyst estimates of C$360.20 million. As a group, analysts expect that Extendicare Inc. will post 0.6134729 EPS for the current fiscal year.
Extendicare Dividend Announcement
The company also recently declared a monthly dividend, which will be paid on Friday, November 15th. Stockholders of record on Thursday, October 31st will be issued a dividend of $0.04 per share. The ex-dividend date of this dividend is Thursday, October 31st. This represents a $0.48 annualized dividend and a dividend yield of ∞. Extendicare’s dividend payout ratio is 70.59%.
About Extendicare
Extendicare Inc, through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties.
Featured Stories
- Five stocks we like better than Extendicare
- Bank Stocks – Best Bank Stocks to Invest In
- Texas Roadhouse Stock Steering for New Highs This Year
- 5 discounted opportunities for dividend growth investors
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- How to Buy Cheap Stocks Step by Step
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.